NCT03257280 Trial on Impact on the Hospital Stay, of an Early Oral Nutrition Protocol Applied to Patients After Total Gastrectomy. (DOPGT_2015) Status UNKNOWN Phase NA
NCT03253939 Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Gastric Cancer Status COMPLETED Phase N/A
NCT03251430 Bone Microstructure by Using HR-pQCT in Long Courses After Gastrectomy Status UNKNOWN Phase N/A
NCT03250091 Surveillance of Patients With Precancerous Lesions of the Stomach Status RECRUITING Phase N/A
NCT03238404 Neoadjuvant Chemotherapy for Patients With Advanced Gastric Cancer in ERAS Programs for Radical Gastrectomy Status COMPLETED Phase NA
NCT03236051 Multimodal Analgesia in Laparoscopic Radical Gastrectomy With Gastric Cancer: a Multi-center Study Status UNKNOWN Phase NA
NCT03229096 Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric Cancer Status UNKNOWN Phase PHASE2
NCT03228667 QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03228095 Volatiles in Breath and Headspace Analysis - Diagnostic Markers Status ENROLLING_BY_INVITATION Phase N/A
NCT03221426 Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585) Status COMPLETED Phase PHASE3
NCT03219593 Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer Status UNKNOWN Phase PHASE2
NCT03210298 International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Status UNKNOWN Phase N/A
NCT03208621 Evaluation of PET and Laparoscopy in STagIng Advanced Gastric Cancer Status UNKNOWN Phase N/A
NCT03196791 Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient Status COMPLETED Phase PHASE3
NCT03190941 Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients Status RECRUITING Phase PHASE1/PHASE2
NCT03179579 Efficacy of HIPEC Combined With Systemic Chemotherapy and CRS on Peritoneal Metastases From Gastric Cancer Status UNKNOWN Phase PHASE3